Canterbury DHB


Myelosuppression Post RIC SCT/DLI

Patients with myelosuppression secondary to DLI should be managed as follows:

About this Canterbury DHB document (8892):

Document Owner:

Andrew Butler (see Who's Who)

Last Reviewed:

December 2016

Next Review:

December 2018


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 8892